APA (7th ed.) Citation

Jiang, S., & Zhong, C. (2025). Glioma drug development benefits from emerging phase 0 and window-of-opportunity trial paradigm. Cell Communication & Signaling, 23(1), 1. https://doi.org/10.1186/s12964-025-02408-4

Chicago Style (17th ed.) Citation

Jiang, Shenzhong, and Chunlong Zhong. "Glioma Drug Development Benefits from Emerging Phase 0 and Window-of-opportunity Trial Paradigm." Cell Communication & Signaling 23, no. 1 (2025): 1. https://doi.org/10.1186/s12964-025-02408-4.

MLA (9th ed.) Citation

Jiang, Shenzhong, and Chunlong Zhong. "Glioma Drug Development Benefits from Emerging Phase 0 and Window-of-opportunity Trial Paradigm." Cell Communication & Signaling, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12964-025-02408-4.